Product Information
AZSTARYS 26.1 MG-5.2 MG CAP is a brand product labeled by Corium, LLC., priced at $14.4011 per EA under NDC 65038028699. Its NADAC has been published 202 times since Nov 23, 2022.
FDA first approved this application on May 7, 2021.
Strength
5.2; 26.1 mg/1; mg/1
Manufacturer
Corium, LLC.NDC
65038028699
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA212994FDA Approved
5/7/2021
On Market Since
7/16/2021
Pharmacological Classes
Price Statistics
The NADAC for AZSTARYS 26.1 MG-5.2 MG CAP has been published 202 times since Nov 23, 2022, and over the history we have for it it has risen 16.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $14.4011 per EA |
|---|---|
| All-time high | $14.4373 (May 13, 2026) |
| All-time low | $12.3221 (Nov 23, 2022) |
| 52-week high | $14.4373 |
| 52-week low | $13.8818 |
| Median price | $13.3998 |
| Average price | $13.4737 |
| Largest weekly change | +4.0% (Jan 3, 2024) |
| Weeks tracked | 202 |
| Tracking since | Nov 23, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Serdexmethylphenidate and Dexmethylphenidate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Corium, LLC. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Serdexmethylphenidate and Dexmethylphenidate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AZSTARYS 26.1 MG-5.2 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for AZSTARYS 26.1 MG-5.2 MG CAP, manufactured by Corium, LLC., is $14.4011 per EA (NDC 65038028699), effective Sep 30, 2026.
How has the price of AZSTARYS 26.1 MG-5.2 MG CAP changed over time?
Over the history we have for it, the NADAC for AZSTARYS 26.1 MG-5.2 MG CAP has risen 16.9%. It has been tracked across 202 weekly CMS publications since Nov 23, 2022.
What are the highest and lowest recorded NADAC prices for AZSTARYS 26.1 MG-5.2 MG CAP?
Since Nov 23, 2022, the NADAC for AZSTARYS 26.1 MG-5.2 MG CAP has ranged from a low of $12.3221 (Nov 23, 2022) to a high of $14.4373 (May 13, 2026), with a median of $13.3998 per EA.
Are there cheaper alternatives to AZSTARYS 26.1 MG-5.2 MG CAP?
No other NADAC-published product currently shares the active ingredient and strength of AZSTARYS 26.1 MG-5.2 MG CAP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures AZSTARYS 26.1 MG-5.2 MG CAP?
AZSTARYS 26.1 MG-5.2 MG CAP (NDC 65038028699) is labeled by Corium, LLC., and CMS classifies it as a brand product.